FACC home

clinical team

clinical trials

treatment options

about cancer

ways to give

saying goodbye

CSU pet hospice

emotional support

related links

join our mailing list
join our mailing list
events calendar

There are no events to display for this time period.

Follow us on Facebook Veterinary Teaching Hospital
CSU Campaign
Advancing Cancer Treatment
| Share

CSU Animal Cancer Center Clinical Trial

Patient Disease:
Canine Lymphoid Neoplasia (relapsed)

Study Name:
Protocol for the Combined Use of TANOVEA™ (Rabacfosadine for Injection) and Asparaginase in Dogs with Relapsed Lymphoma

Purpose of the study:

  • To evaluate efficacy of rabacfosadine combined with l-asparaginase to treat dogs with relapsed lymphoma

Primary Eligibility Criteria:

  • Dogs diagnosed with lymphoma
  • Prior to enrollment dogs must undergo some eligibility testing and be deemed free of other underlying diseases
  • Chest x-rays are strongly recommended

Study Protocol:

  • Pre-enrollment: Physical exam blood work and urine testing, cytology or histology of tumor, immunophenotyping of the tumor
  • Rabacfosadine will be administered Day 0 (first day of the clinical trial), Day 21, Day 42, Day 63, and Day 84; at each visit there will be a physical exam and blood testing and urinalysis performed
  • L-asparaginase will be administered Day 0 and day 21.
  • Day 7: physical exam and blood test
  • Once this treatment protocol is finished, the patient will be rechecked monthly

Owner Responsibilities:

  • To make and keep all appointment according to study protocol, and follow up examinations

Financial Incentives:

  • Clients will receive rabacfosadine at no cost.
  • Clients will be responsible for costs of l-asparaginase, recheck exams, blood tests and any ancillary medications, as well as treatment of any side effects that occur

If you have further questions about any of our clinical trials, Please either login or sign up to submit a consulting form. Your consult will then be directed to an appropriate oncology clinician. Requests are typically returned within 5 business days